TrialThe oncologist2020

A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.

Imane El Dika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.